Biological activity-based modeling identifies antiviral leads against SARS-CoV-2

Ruili Huang(National Institutes of Health), Wei Zheng(Liaoning Cancer Hospital & Institute), Catherine Z. Chen(National Institutes of Health), Khalida Shamim(National Institutes of Health), Danielle Bougie(National Institutes of Health), Emily M. Lee(Florida State University), Menghang Xia(National Center for Advancing Translational Sciences), Hengli Tang(Florida State University), Wenwei Huang(National Institutes of Health), Xiangguo Qiu(Public Health Agency of Canada), Christopher P. Austin(Unknown), Anton Simeonov(National Institutes of Health), Li Zhang(Fourth Hospital of Changsha), Miao Xu(National Institutes of Health), Jinghua Zhao(Sun Yat-sen University), Wei Zhu(Shanghai Tenth People's Hospital), Hu Zhu(National Center for Advancing Translational Sciences), Donald C. Lo(Center for Translational Molecular Medicine), Mathew D. Hall(National Institutes of Health), Shihua He(Public Health Agency of Canada)
Nature Biotechnology
February 23, 2021
Cited by 54


Related Papers